Who funds Alzheimer's disease research?
We count 415 funded Alzheimer's disease projects, active between 2019 and 2034, from 5 funders. The most came from NIH · NIA (257 projects), EU · MSCA (44 projects) and EU · ERC (37 projects). The median award is $4M, across the 404 of 415 projects that list an amount.
- Funded projects
- 415
- Funders
- 5
- Median award
- $4M
- Open calls now
- 14
Top funders of Alzheimer's disease research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| NIH · NIA | 257 | 62% | $4.6M |
| EU · MSCA | 44 | 11% | $258K |
| EU · ERC | 37 | 9% | $2.1M |
| Wellcome | 22 | 5% | $2.2M |
| NIH · NINDS | 15 | 4% | $3.6M |
| EU · Health | 7 | 2% | $9.1M |
| EU · Widening participation and spreading excellence | 6 | 1% | $1.2M |
| NIH · Office of the Director | 3 | 1% | $4.5M |
| EU · EIC | 3 | 1% | $2.6M |
| UKRI · MRC | 3 | 1% | $925K |
Projects whose title or summary mentions Alzheimer's disease. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open Alzheimer's disease funding calls
14 open calls mention Alzheimer's disease today; the 12 most on-topic are listed.
-
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
National Institutes of HealthNot specifiedDeadline: November 10, 2026 ·
-
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of HealthNot specifiedDeadline: November 19, 2026 ·
-
Scientists Pursuing Alzheimer's/Related Dementias Research in Kentucky (SPARK) Program
Alzheimer's AssociationNot specifiedDeadline: February 2, 2027 ·
-
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of HealthUp to $1,500,000Deadline: November 5, 2027 ·
-
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of HealthUp to $1,000,000Deadline: May 7, 2028 ·Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
-
Alzheimer's Association Funding Program for Global Real-World Data Programs (ALZ-RWD)
Alzheimer's AssociationNot specifiedDeadline: Not listed
-
Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)
Alzheimer's AssociationNot specifiedDeadline: Not listed
-
Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN): Powering the Next Generation of Research
Alzheimer's AssociationNot specifiedDeadline: October 30, 2026 ·
-
BRING IT: Brain Research & Innovation Network – Grant Initiative of Texas
Alzheimer's AssociationNot specifiedDeadline: November 13, 2026 ·
-
Zenith Fellows Award Program (ZENITH)
Alzheimer's AssociationNot specifiedDeadline: March 30, 2027 ·
-
NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
National Institutes of HealthUp to $400,000Deadline: May 26, 2027 ·
-
NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
National Institutes of HealthUp to $200,000Deadline: May 26, 2027 ·
Real odds
- About 1 in 8 funded · 13% · NIH R01-equivalent grants, all NIH institutes, FY2025 · NIH Data Book, report 29
Published success rates for the programs behind the open calls above: the share of applications the funder funded, program-wide, not for this topic.
Forecast: announced, not open yet
8 forecast calls on Alzheimer's disease. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.
-
ForecastFunctional Target Validation for Alzheimer's Disease-Related Dementias
National Institutes of HealthNot specifiedExpected to open May 5, 2026
-
ForecastThe NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)
National Institutes of HealthNot specifiedExpected to open September 1, 2026
-
ForecastAlzheimer's Disease Programs Initiative (ADPI) - States and Community Grants
Administration for Community Living$850,000 – $1,000,000Expected to open March 1, 2027
-
ForecastAlzheimer's Disease Programs Initiative (ADPI) - Dementia Capability in Indian Country
Administration for Community Living$200,000 – $300,000Expected to open March 1, 2027
-
ForecastAlzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network
Administration for Community Living$200,000 – $250,000Expected to open March 4, 2027
-
ForecastAlzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of HealthNot specifiedExpected to open March 10, 2027
-
ForecastGenomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of HealthNot specifiedExpected to open July 1, 2026
-
ForecastAlheimer's Disease Programs Initiative (ADPI) - State Programs for Dementia Specific Respite
Administration for Community Living$500,000 – $4,000,000Expected to open March 1, 2027
Funded Alzheimer's disease projects
A sample, latest start first, at most three per program.
-
Seeing inside the brain: the in-tissue structure of living and postmortem Alzheimer’s disease human donor brain by high-resolution cryo-electron tomography.
Wellcome · £4,800,000 · ends 2034
-
Does menopause enhance Alzheimer’s Disease risk by exacerbating vascular dysfunction?
Wellcome · £1,686,636 · ends 2033
-
Amyloid clearing therapy in dementia with Lewy bodies plus Alzheimers disease (ACT DLB+)
NIH · NINDS · $4,161,896 · ends 2033
-
From Cohort to Molecular Insights: Integrating an African-Centric iPSC Biobank to Decipher the Role of APOE and Ancestry in Alzheimer's Disease
Wellcome · £2,888,884 · ends 2033
-
Alzheimer's Gut Microbiome Project
NIH · NIA · $11,142,148 · ends 2031
-
TARGET-AD: A Precision Medicine Framework for Alzheimer’s Disease
NIH · NIA · $8,231,369 · ends 2031
-
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
NIH · NIA · $4,832,454 · ends 2031
-
CAREER: Integrating the chemistry and biological organization of neuroactive alkaloid biosynthesis
NSF · BIO · $1,599,999 · ends 2031
-
ICF Understanding the link between sleep and Alzheimer’s
UKRI · MRC · £4,326,301 · ends 2030
-
Identification of novel botanical derived NRF2 activating agents with potential against Alzheimer’s disease from Malagasy plants
NIH · Fogarty · $3,396,376 · ends 2030
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “alzheimer”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with Alzheimer's disease calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free